Implant Sciences Corporation Announces New Location For Annual Shareholders Meeting
Relocation Necessary to Allow Demonstration of Prototype Explosive Detection Equipment at Meeting
WAKEFIELD, Mass., Dec. 6 /PRNewswire/ -- Implant Sciences Corporation (Amex: IMX - news, IMX.WS - news), which develops products for the radiation oncology, interventional cardiology, orthopedic and explosives detection marketplaces, today announced that its annual shareholders meeting, scheduled for December 14, 2001, will be held in the Montrose Room at the Sheraton Colonial Hotel in Wakefield, Massachusetts. The hotel, which is located at 1 Audubon Road, Wakefield (less than a mile from Implant Sciences' headquarters), has been selected to accommodate a higher than expected turnout for the annual meeting. In addition, the starting time for the annual shareholders meeting has been delayed one half hour and will now begin at 10:30 a.m.
After the meeting, Implant Sciences Corporation scientists will demonstrate the capabilities of the Company's new explosives vapor detection system, which can detect trace amounts of certain explosives at the parts per trillion levels. Such trace amounts can be detected in approximately one second. For comparison purposes, it is generally accepted that trained bomb-sniffing dogs can detect explosives at the parts per billion levels. The unit to be shown will be a portable version of the explosives vapor detection system. It is anticipated that these portable systems may be used to survey buildings for suspected bombs, to check baggage and personnel at airport security entrances, government facilities, convention centers, sport facilities, etc.
Implant Sciences Corporation is headquartered in Wakefield, Massachusetts, and its common stock is listed on the American Stock Exchange under the ticker symbol ``IMX.''
This press release includes statements that may constitute ``forward-looking'' statements, usually containing the words ``believe'', ``estimate'', ``project'', ``expect'' or similar expressions. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Factors that would cause or contribute to such differences include, but are not limited to, continued acceptance of the Company's products and services in the marketplace, the ability of the Company to develop effective new products and receive governmental approvals of such products, competitive factors, dependence upon third-party vendors, and other risks detailed in the Company's periodic report filings with the Securities and Exchange Commission. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this release. |
